Advertisement

Pharmaceutisch Weekblad

, Volume 12, Issue 3, pp 91–96 | Cite as

Drug-utilization studies in the Netherlands

  • F. M. Haaijer-Ruskamp
Review Articles

Abstract

Drug-utilization research is a research area of increasing importance, both in the Netherlands and elsewhere. In this article an overview of the situation in the Netherlands is given. Three types of studies are distinguished: descriptive studies, studies of the determinants of drug use and studies of the impact of drug use. Descriptive studies are needed to understand the present situation and to detect problems. If these problems are to be solved it is important to understand the factors that determine drug use. In the Netherlands research in the latter area is focused on the influence of policy measures and of educational measures for physicians, as well as for the general public. The main body of research into the impact of drug use is the study of adverse effects, but increasingly attention is paid to the effect on quality of life in a broader sense. A number of data bases exist that enable drug-utilization research. At present one of the main problems concerning the data bases is the absence of adequate diagnosis-related drug-utilization data. Despite the existence of a number of shortcomings and problems, the general impression of drug-utilization research in the Netherlands is one of a flourishing field of study.

Keywords

Data collection Drug utilization Epidemiologic methods Netherlands Research 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Haaijer-Ruskamp FM, Dukes MNG. Drugs and money. 5th Draft report. Copenhagen/Groningen: WHO, Regional Office for Europe/University of Groningen, 1986.Google Scholar
  2. 2.
    Bakker A. Vergelijking met het buitenland: is Nederland anders? [Comparison with foreign countries: are the Netherlands different?] Pharm Weekbl 1989;124:950–5.Google Scholar
  3. 3.
    De Jong-van den Berg LTW. Registration of drug use during pregnancy and lactation in computerized community pharmacies. Tijdschr Soc Gezondheidszorg 1989;67:20.Google Scholar
  4. 4.
    Haaijer-Ruskamp FM, Dingemans CAJ. Psychofarmacagebruik bij ouderen. Teveel? van het goede? [Psychotropic drugs for the elderly. Too much? Of a good thing?] Practitioner 1988:1007–13.Google Scholar
  5. 5.
    Haaijer-Ruskamp FM, Stewart R, Wesseling H. Het geneesmiddelengebruik van ouderen [Drug use by the elderly]. Report of the Department of Health Sciences and Pharmacology/Clinical Pharmacology. Groningen: University of Groningen, 1988.Google Scholar
  6. 6.
    Dingemans CAJ, Haaijer-Ruskamp FM, Wesseling H. Prescriptie van geneesmiddelen aan ouderen in de huisartspraktijk: verschillen tussen zelfstandig wonenden en bewoners van verzorgingstehuizen [Drug prescriptions for the elderly in general practice; differences between patients living at home and in homes for the aged]. In: Schroots JJF, ed. Gezond zijn is ouder worden [Being healthy means growing old]. Assen: Van Gorcum, 1989:55–60.Google Scholar
  7. 7.
    Haaijer-Ruskamp FM, Dingemans CAJ. Wat krijgen ouderen aan geneesmiddelen, thuis en in het verzorgingstehuis? [What medicines do the elderly get at home or in homes for the aged?] Geriatrie Inform 1989; E3020/1-3020/11.Google Scholar
  8. 8.
    Hekster YA, Terpstra MJ, Lippens R, Geven W. Drug utilization in hospitalized children [Abstract]. Pharm Weekbl [Sci] 1989;11(Suppl F):F5.Google Scholar
  9. 9.
    Hardon A. De ontwikkeling van nieuwe hormonale middelen [The development of new hormone preparations]. Wetenschap en Samenleving 1985;6.Google Scholar
  10. 10.
    Wolffers I, Hardon A, Janssen J. Marketing fertility. Women, menstruation and the pharmaceutical industry. Amsterdam: WEMOS, 1989.Google Scholar
  11. 11.
    Bertens AM, Geldof TML, Mes NTh, et al. Verschuivingen op recept [Prescribed changes] [Rapport]. Amstelveen: Ziekenfondsraad, 1989.Google Scholar
  12. 12.
    Van der Geest S, Hardon A. Western Pharmaceuticals in Third World countries: methodological suggestions for field research. Health Policy Planning 1988;3:152–8.Google Scholar
  13. 13.
    Hardon A. The use of modern Pharmaceuticals in a Filipino village: doctors' prescriptions and selfmedication. Soc Sci Med 1987;25:277–92.CrossRefPubMedGoogle Scholar
  14. 14.
    Hardon A. Towards rational drug use in urban primary health care. Drug Monitor 1988;3:111–9.Google Scholar
  15. 15.
    Denig P, Haaijer-Ruskamp FM, Zijsling D. How physicians choose their drugs. Soc Sci Med 1988;27:1381–6.CrossRefPubMedGoogle Scholar
  16. 16.
    Denig P, Haaijer-Ruskamp FM, Zijsling D. Arts en geneesmiddelinformatie [The physician and drug information]. Groningen: Styx Publications, 1988.Google Scholar
  17. 17.
    Denig P, Haaijer-Ruskamp FM, Zijsling D. The impact of a drug bulletin on knowledge, drug evaluation and prescribing of physicians. Drug Intell Clin Pharm 1990;24:87–93.Google Scholar
  18. 18.
    Van de Poel GTh. Samenwerking van huisartsen en apothekers [Collaboration of general practitioners and pharmacists] [Dissertation]. Rotterdam: Erasmus University Rotterdam, 1988.Google Scholar
  19. 19.
    Paes AHP. Apotheker en artsen in overleg? [Pharmacist and physicians in consultation? [Dissertation]. Utrecht: Utrecht University, 1989.Google Scholar
  20. 20.
    Bureau van Hummel. Onderzoek naar de bruikbaarheid van het Farmacotherapeutisch Kompas [A study of the usefulness of the “Drug Therapy Compas”]. Amstelveen: Ziekenfondsraad, 1988.Google Scholar
  21. 21.
    Zijlstra IF, Haaijer-Ruskamp FM, Post D. Overleg tussen regionaal klinisch farmacoloog, huisartsen en apothekers [Consultation between the area clinical pharmacologist, general practitioners and pharmacists]. Med Contact 1989;44:926–8.Google Scholar
  22. 22.
    Van Trigt A, Haaijer-Ruskamp FM, De Jong-van den Berg LTW. Medicines and the menopause; the evaluation of a brochure. Groningen: University of Groningen, 1988.Google Scholar
  23. 23.
    De Jong-van den Berg LTW, Haaijer-Ruskamp FM, Van Trigt AM. Evaluatie van een voorlichtingsbrochure over geneesmiddelen en de overgang [Evaluation of a brochure about medicines and the menopause]. Pharm Weekbl 1989;124:870–6.Google Scholar
  24. 24.
    Van Trigt AM, De Jong-van den Berg LTW, Vos R, Haaijer-Ruskamp FM. Pharma-ROM-informatie of bijsluiter: is er verschil? [Pharma-ROM information or patient package inserts: is there a difference?]. Pharm Weekbl 1990;125:404–9.Google Scholar
  25. 25.
    Petri H, De Vet HCW, Naus J, Urquhart J. Prescription sequence analysis; a new and fast method for assessing certain adverse reactions of prescription drugs in large populations. Stat Med 1988;7:1171–5.PubMedGoogle Scholar
  26. 26.
    Leufkens HGM, Bakker A, Hekster YA. Risk indicators from pharmacy records; a prescription drug use database of patients on antirheumatic therapy. Proceedings of the 4th international conference on pharmacoepidemiology. Chelsea: Lewis Publisher, 1988.Google Scholar
  27. 27.
    Cornel MC, Dukes MNG, De Jong-van den Berg LTW, Meyboom RHB. Ovulation induction and neural tube defects. Lancet 1989;1:1386.CrossRefGoogle Scholar
  28. 28.
    Dukes MNG, ed. Meyler's side effects of drugs. 11th ed. Amsterdam: Elsevier Science Publishers, 1988.Google Scholar
  29. 29.
    Dukes MNG, ed. Side effects of drugs annual 12. Amsterdam: Elsevier Science Publishers, 1988.Google Scholar
  30. 30.
    Dukes MNG, Swartz B. Responsibility for drug induced injury. Amsterdam: Elsevier Science Publishers, 1988.Google Scholar
  31. 31.
    Herings RMC. Effecten van chronisch en gecombineerd gebruik van geneesmiddelen [The effects of chronic and combined medicine use]. Utrecht: Utrecht University, 1989.Google Scholar
  32. 32.
    Rwiza HT, Keyser A, Hekster YA, Pool M, Verwey H. Retrospective analysis of drug treatment in epileptic patients. Pharm Weekbl [Sci] 1989;11:50–5.Google Scholar

Copyright information

© Royal Dutch Association for Advancement of Pharmacy 1990

Authors and Affiliations

  • F. M. Haaijer-Ruskamp
    • 1
  1. 1.Department of Health Sciences and Department of Pharmacology/Clinical PharmacologyUniversity of GroningenAV GroningenThe Netherlands

Personalised recommendations